RetractedArticleClinical & translational immunology2019

Dual targeting of RANKL and PD-1 with a bispecific antibody improves anti-tumor immunity.

William C Dougall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.